Bing Han (Mao Zhang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Particulate Matter

Hepatitis B Virus

Long Noncoding Rna

Signaling Pathway

Top Venues

Cell death & disease

NPJ precision oncology

OncoTargets and therapy

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Youpeng Wang, Ziyin Zhao, Tingting Guo, Tiansong Wu, Mao Zhang, Dingan Luo, Kunpeng Dou, Yeni Yang, Cheng Jin, Bingyuan Zhang, Bin Zhang, Bing Han
SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis. NPJ precision oncology 8 (1) (2024)
Youpeng Wang, Ziyin Zhao, Tingting Guo, Tiansong Wu, Mao Zhang, Dingan Luo, Kunpeng Dou, Yeni Yang, Cheng Jin, Bingyuan Zhang, Bin Zhang, Bing Han
SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis. NPJ precision oncology 8 (1) (2024)
Dingan Luo, Youpeng Wang, Mao Zhang, Haoran Li, Deze Zhao, Hui Li, Xiaowu Chen, Cheng Jin, Bing Han
SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1α-dependent mitochondrial damage. Cell death & disease 13 (11) (2022)
Dingan Luo, Haoran Li, Heng Yu, Bing Han, Jianchong Hu, Cheng Jin, Meisze Chua, Bing Han
Predictive value of preoperative and postoperative peripheral lymphocyte difference in hepatitis B virus-related hepatocellular cancer patients: Based on the analysis of dynamic nomogram. Journal of surgical oncology 122 (8) (2020)
Mao Zhang, Mei-Sze Chua, Jie Hu, Haoran Li, Shun Zhang, Liqun Wu, Bing Han
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection. Cancer management and research 11 (2019)
Mao Zhang, Shihai Liu, Mei-Sze Chua, Haoran Li, Dingan Luo, Sheng Wang, Shun Zhang, Bing Han, Chuandong Sun
SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell death & disease 10 (8) (2019)
Mao Zhang, Shihai Liu, Mei-Sze Chua, Haoran Li, Dingan Luo, Sheng Wang, Shun Zhang, Chuandong Sun, Bing Han
Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell death & disease 10 (11) (2019)
Bing Han, Jiawei Huang, Zhenjie Yang, Jiaqi Zhang, Xiaomin Wang, Ning Xu, Haining Meng, Junyu Wu, Qiao Huang, Xi Yang, Ruowu Shen, Chuandong Sun
miR-449a Is Related to Short-Term Recurrence of Hepatocellular Carcinoma and Inhibits Migration and Invasion by Targeting Notch1. OncoTargets and therapy 12 (2019)